These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2219678)

  • 21. Antagonism of morphine-induced respiratory depression with nalmefene.
    Konieczko KM; Jones JG; Barrowcliffe MP; Jordan C; Altman DG
    Br J Anaesth; 1988 Sep; 61(3):318-23. PubMed ID: 3140862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose.
    Kaplan JL; Marx JA; Calabro JJ; Gin-Shaw SL; Spiller JD; Spivey WL; Gaddis GM; Zhao N; Harchelroad FP
    Ann Emerg Med; 1999 Jul; 34(1):42-50. PubMed ID: 10381993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sedative effects of low-dose medetomidine and butorphanol alone and in combination intravenously in dogs.
    Girard NM; Leece EA; Cardwell J; Adams VJ; Brearley JC
    Vet Anaesth Analg; 2010 Jan; 37(1):1-6. PubMed ID: 20017813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF; Nishimura S; Goodman RR; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiopulmonary effects of butorphanol tartrate in dogs.
    Trim CM
    Am J Vet Res; 1983 Feb; 44(2):329-31. PubMed ID: 6830022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of ketoprofen, oxymorphone hydrochloride, and butorphanol in the treatment of postoperative pain in dogs.
    Pibarot P; Dupuis J; Grisneaux E; Cuvelliez S; Planté J; Beauregard G; Bonneau NH; Bouffard J; Blais D
    J Am Vet Med Assoc; 1997 Aug; 211(4):438-44. PubMed ID: 9267504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of Opioid-Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone.
    Ellison M; Hutton E; Webster L; Skolnick P
    J Clin Pharmacol; 2024 Jul; 64(7):828-839. PubMed ID: 38436495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of beta-funaltrexamine on butorphanol dependence.
    Oh KW; Makimura M; Jaw SP; Hoskins B; Ho IK
    Pharmacol Biochem Behav; 1992 May; 42(1):29-34. PubMed ID: 1528943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nalmefene for elective reversal of procedural sedation in children.
    Chumpa A; Kaplan RL; Burns MM; Shannon MW
    Am J Emerg Med; 2001 Nov; 19(7):545-8. PubMed ID: 11698998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sedative effects of intramuscular low-dose medetomidine in combination with butorphanol or methadone in dogs.
    Puighibet Z; Costa-Farré C; Santos L; Canfrán S; Gómez de Segura IA
    Vet Anaesth Analg; 2015 Nov; 42(6):590-6. PubMed ID: 25800204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analgesia and behavioral responses of dogs given oxymorphone-acepromazine and meperidine-acepromazine after methoxyflurane and halothane anesthesia.
    Sawyer DC; Rech RH; Adams T; Durham RA; Richter MA; Striler EL
    Am J Vet Res; 1992 Aug; 53(8):1361-8. PubMed ID: 1510312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of sedative and cardiorespiratory effects of medetomidine and medetomidine-butorphanol combination in dogs.
    Ko JC; Bailey JE; Pablo LS; Heaton-Jones TG
    Am J Vet Res; 1996 Apr; 57(4):535-40. PubMed ID: 8712521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Butorphanol does not reduce the minimum alveolar concentration of halothane in dogs.
    Quandt JE; Raffe MR; Robinson EP
    Vet Surg; 1994; 23(2):156-9. PubMed ID: 8191676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duration of opioid antagonism by nalmefene and naloxone in the dog: an integrated pharmacokinetic/pharmacodynamic comparison.
    Veng-Pedersen P; Wilhelm JA; Zakszewski TB; Osifchin E; Waters SJ
    J Pharm Sci; 1995 Sep; 84(9):1101-6. PubMed ID: 8537889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intramuscular administration of low doses of medetomidine and medetomidine-butorphanol in middle-aged and old dogs.
    Muir WW; Ford JL; Karpa GE; Harrison EE; Gadawski JE
    J Am Vet Med Assoc; 1999 Oct; 215(8):1116-20. PubMed ID: 10530324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.
    Kim S; Wagner HN; Villemagne VL; Kao PF; Dannals RF; Ravert HT; Joh T; Dixon RB; Civelek AC
    J Nucl Med; 1997 Nov; 38(11):1726-31. PubMed ID: 9374341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses.
    Giles T; Sander G; Merz H
    Eur J Pharmacol; 1983 Nov; 95(3-4):247-52. PubMed ID: 6197313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of sedation in dogs: methadone or butorphanol in combination with dexmedetomidine intravenously.
    Trimble T; Bhalla RJ; Leece EA
    Vet Anaesth Analg; 2018 Sep; 45(5):597-603. PubMed ID: 30077553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative cardiovascular, analgesic, and sedative effects of medetomidine, medetomidine-hydromorphone, and medetomidine-butorphanol in dogs.
    Kuo WC; Keegan RD
    Am J Vet Res; 2004 Jul; 65(7):931-7. PubMed ID: 15281651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naloxone, naltrexone, and related noroxymorphones.
    Blumberg H; Dayton HB
    Adv Biochem Psychopharmacol; 1973; 8(0):33-43. PubMed ID: 4794989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.